التفاصيل البيبلوغرافية
العنوان: |
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial |
المؤلفون: |
Goldschmidt, Hartmut, Mai, Elias K, Bertsch, Uta, Fenk, Roland, Nievergall, Eva, Tichy, Diana, Besemer, Britta, Dürig, Jan, Schroers, Roland, von Metzler, Ivana, Hänel, Mathias, Mann, Christoph, Asemissen, Anne M, Heilmeier, Bernhard, Weinhold, Niels, Huhn, Stefanie, Kriegsmann, Katharina, Luntz, Steffen P, Holderried, Tobias A W, Trautmann-Grill, Karolin, Gezer, Deniz, Klaiber-Hakimi, Maika, Müller, Martin, Khandanpour, Cyrus, Knauf, Wolfgang, Scheid, Christof, Munder, Markus, Geer, Thomas, Riesenberg, Hendrik, Thomalla, Jörg, Hoffmann, Martin, Raab, Marc S, Salwender, Hans J, Weisel, Katja C, Behringer, Joachim, Bernhard, Helga, Bernhardt, Christiane, Blau, Igor W, Bolling, Claus, Debatin, Daniel, Dingeldein, Gerrit, Ferstl, Barbara, Fest, Claudia, Fronhoffs, Stefan, Fuhrmann, Stephan |
المصدر: |
The Lancet Haematology ; volume 9, issue 11, page e810-e821 ; ISSN 2352-3026 |
بيانات النشر: |
Elsevier BV |
سنة النشر: |
2022 |
المجموعة: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
مصطلحات موضوعية: |
Hematology |
نوع الوثيقة: |
article in journal/newspaper |
اللغة: |
English |
DOI: |
10.1016/s2352-3026(22)00263-0 |
الإتاحة: |
https://doi.org/10.1016/s2352-3026Test(22)00263-0 https://api.elsevier.com/content/article/PII:S2352302622002630?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S2352302622002630?httpAccept=text/plainTest |
حقوق: |
https://www.elsevier.com/tdm/userlicense/1.0Test/ ; https://doi.org/10.15223/policy-017Test ; https://doi.org/10.15223/policy-037Test ; https://doi.org/10.15223/policy-012Test ; https://doi.org/10.15223/policy-029Test ; https://doi.org/10.15223/policy-004Test |
رقم الانضمام: |
edsbas.6E29A781 |
قاعدة البيانات: |
BASE |